Status:
WITHDRAWN
Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
EARLY_PHASE1
Brief Summary
A proof of concept clinical trial to assess the synergism of curcumin (CURC) and ursolic acid (UA). Before further testing within formal cancer clinical trials, we must (1) evaluate the bioavailabilit...
Detailed Description
Once a subject is identified that may meet eligibility criteria, the physician and/or study investigators will be alerted to the potential candidate and will introduce the study to the patient at thei...
Eligibility Criteria
Inclusion
- Have proven diagnosis of prostate cancer with Gleason Group 3 or lower and planning to undergo radical prostatectomy
- Be able to give informed consent
- Be age 18 or older
- Able to stop supplements
Exclusion
- Unable to give informed consent
- Age \< 18
- High-risk prostate cancer or suspected metastasis
- Unable to swallow pills
- Unable to stop supplements
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04403568
Start Date
October 1 2021
End Date
December 1 2023
Last Update
September 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mays Cancer Center
San Antonio, Texas, United States, 78229